{"id":340717,"date":"2025-08-20T12:18:39","date_gmt":"2025-08-20T12:18:39","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-tg-therapeutics\/"},"modified":"2025-08-20T12:18:39","modified_gmt":"2025-08-20T12:18:39","slug":"how-to-buy-tg-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/","title":{"rendered":"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-340717","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"TG Therapeutics, Inc. (TGTX) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu umut vadeden biyoteknoloji hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin.","description_source":{"label":"Description","type":"textarea","formatted_value":"TG Therapeutics, Inc. (TGTX) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 ve bu umut vadeden biyoteknoloji hissesine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131 \u00f6\u011frenin. G\u00fcncel fiyat, riskler ve 2025-2030 b\u00fcy\u00fcme potansiyelini ke\u015ffedin."},"intro":"Multipl skleroz tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7an bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? TG Therapeutics, Inc. (TGTX), amiral gemisi ilac\u0131 BRIUMVI'nin patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesiyle heyecan verici bir b\u00fcy\u00fcme potansiyeli sunuyor. Bu, yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fcz\u00fc olu\u015ftururken t\u0131bbi bir at\u0131l\u0131m hikayesine dahil olma \u015fans\u0131n\u0131z olabilir.","intro_source":{"label":"Intro","type":"text","formatted_value":"Multipl skleroz tedavisinde \u00e7\u0131\u011f\u0131r a\u00e7an bir biyoteknoloji \u015firketine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? TG Therapeutics, Inc. (TGTX), amiral gemisi ilac\u0131 BRIUMVI'nin patlay\u0131c\u0131 gelir b\u00fcy\u00fcmesiyle heyecan verici bir b\u00fcy\u00fcme potansiyeli sunuyor. Bu, yat\u0131r\u0131m portf\u00f6y\u00fcn\u00fcz\u00fc olu\u015ftururken t\u0131bbi bir at\u0131l\u0131m hikayesine dahil olma \u015fans\u0131n\u0131z olabilir."},"body_html":"<h2>\ud83d\udcc8 TG Therapeutics Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>20 A\u011fustos 2025 itibar\u0131yla TG Therapeutics, Inc. (TGTX) NASDAQ'ta <strong>28,08 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>3-5 Kas\u0131m 2025<\/strong> kesinlikle kritik - \u015firketin 3. \u00e7eyrek kazan\u00e7 raporlar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131 tarih. Tarihsel olarak, bu raporlar b\u00fcy\u00fck fiyat hareketlerine neden olur.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 TGTX Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>4 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>34,20 $<\/td><td><strong>-%18<\/strong> (kazan\u00e7 hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>5 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>32,80 $<\/td><td><strong>+%8,5<\/strong> (gelir beklentisi a\u015f\u0131ld\u0131)<\/td><\/tr> <tr><td>10 \u015eub 2025<\/td><td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td><td>29,50 $<\/td><td><strong>+%12<\/strong> (yol g\u00f6sterici art\u0131\u015f\u0131)<\/td><\/tr> <tr><td>4 Kas 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>27,80 $<\/td><td><strong>+%15<\/strong> (BRIUMVI b\u00fcy\u00fcmesi)<\/td><\/tr> <tr><td>5 A\u011fu 2024<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>25,10 $<\/td><td><strong>+%22<\/strong> (pazar geni\u015flemesi)<\/td><\/tr> <tr><td>6 May 2024<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>22,40 $<\/td><td><strong>+%18<\/strong> (FDA g\u00fcncellemeleri)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: TGTX, kazan\u00e7 raporlar\u0131na kar\u015f\u0131 a\u015f\u0131r\u0131 duyarl\u0131l\u0131k g\u00f6steriyor ve ortalama \u00b1%15 dalgalanma ya\u015fan\u0131yor. Pozitif s\u00fcrprizler patlay\u0131c\u0131 kazan\u00e7lar yarat\u0131rken, hedef ka\u00e7\u0131rmalar keskin d\u00fc\u015f\u00fc\u015flere neden oluyor. Son 2. \u00e7eyrek sonras\u0131 %18\u2019lik d\u00fc\u015f\u00fc\u015f, bu biyoteknoloji hissesinin ne kadar volatil olabilece\u011fini g\u00f6steriyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2> <p>TG Therapeutics hisseleri ini\u015f \u00e7\u0131k\u0131\u015flarla dolu bir yolculuk ya\u015fad\u0131, toplamda <strong>%19,2<\/strong> d\u00fc\u015ft\u00fc ancak inan\u0131lmaz volatilite g\u00f6sterdi:<\/p> <p><strong>\u015eubat<\/strong>: 34,70 $ (y\u0131ll\u0131k rapor sonras\u0131 zirve)<br\/> <strong>Mart<\/strong>: 38,90 $ (BRIUMVI sat\u0131\u015f ivmesi)<br\/> <strong>Nisan<\/strong>: 36,20 $ (kar realizasyonu d\u00f6nemi)<br\/> <strong>May\u0131s<\/strong>: 35,60 $ (1. \u00e7eyrek kazan\u00e7 sindirimi)<br\/> <strong>Haziran<\/strong>: 32,80 $ (piyasa belirsizli\u011fi)<br\/> <strong>Temmuz<\/strong>: 29,40 $ (sekt\u00f6r genelinde biyoteknoloji sat\u0131\u015flar\u0131)<br\/> <strong>A\u011fustos<\/strong>: 28,08 $ (2. \u00e7eyrek kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015f)<\/p> <p>Volatilitenin sebebi nedir? Biyoteknoloji hisseleri klinik veriler ve \u00e7eyreklik sonu\u00e7lara ba\u011fl\u0131 olarak y\u00fckselir ya da d\u00fc\u015fer. TGTX\u2019in %91 gelir art\u0131\u015f\u0131, 2. \u00e7eyrekteki hisse ba\u015f\u0131na kazan\u00e7 hedefinin ka\u00e7\u0131r\u0131lmas\u0131n\u0131 telafi edemedi; bu sekt\u00f6rde m\u00fckemmellik beklendi\u011fini g\u00f6steriyor.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <h3>2025 (Y\u0131l Sonu): 32-38 $<\/h3> <p>Y\u00fckseltilmi\u015f BRIUMVI rehberli\u011fi 570-575 milyon $ ve olas\u0131 3. \u00e7eyrek toparlanmas\u0131na dayanarak \u2192 <strong>d\u00fc\u015f\u00fc\u015flerde AL<\/strong><\/p> <h3>2026: 45-52 $<\/h3> <p>Yeni b\u00f6lgelere pazar geni\u015flemesi ve olas\u0131 subkutan form\u00fclasyon onay\u0131 bekleniyor<\/p> <h3>2028: 60-75 $<\/h3> <p>\u00dcr\u00fcn hatt\u0131n\u0131n olgunla\u015fmas\u0131 ve BRIUMVI i\u00e7in multipl skleroz d\u0131\u015f\u0131 yeni endikasyonlar<\/p> <h3>2030: 85-110 $<\/h3> <p>B h\u00fccre tedavilerinde pazar liderli\u011fi ve b\u00fcy\u00fck ila\u00e7 \u015firketleri i\u00e7in potansiyel sat\u0131n alma hedefi<\/p> <p><strong>Sonu\u00e7<\/strong>: K\u0131sa vadeli volatiliteye ra\u011fmen g\u00fc\u00e7l\u00fc uzun vadeli tutma potansiyeli. Zay\u0131fl\u0131k d\u00f6nemlerinde biriktirin.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>A\u015f\u0131r\u0131 volatilite<\/strong>: %2,84 g\u00fcnl\u00fck dalgalanmalar normaldir (<a href=\"https:\/\/stockinvest.us\/stock\/TGTX\">StockInvest Verileri<\/a>)<\/li> <li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA incelemesi ilerlemeyi an\u0131nda durdurabilir<\/li> <li><strong>Nakit yak\u0131m\u0131<\/strong>: Negatif 87 milyon $ serbest nakit ak\u0131\u015f\u0131 s\u00fcrekli finansman gerektirir<\/li> <li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Herhangi bir \u00fcr\u00fcn hatt\u0131 gerilemesi hissenin %30-50 d\u00fc\u015fmesine yol a\u00e7abilir<\/li> <li><strong>Rekabet<\/strong>: Daha derin kaynaklara sahip b\u00fcy\u00fck ila\u00e7 \u015firketleri<\/li> <\/ul> <h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>Patlay\u0131c\u0131 b\u00fcy\u00fcme<\/strong>: Y\u0131ll\u0131k %91 BRIUMVI gelir art\u0131\u015f\u0131 (<a href=\"https:\/\/www.stocktitan.net\/news\/TGTX\/tg-therapeutics-reports-second-quarter-2025-financial-results-and-gk27yackstrn.html\">2. \u00c7eyrek Raporu<\/a>)<\/li> <li><strong>Y\u00fckseltilmi\u015f rehberlik<\/strong>: 570-575 milyon $ hedefi y\u00f6netim g\u00fcvenini g\u00f6steriyor<\/li> <li><strong>Pazar geni\u015flemesi<\/strong>: AB, \u0130ngiltere, \u0130svi\u00e7re onaylar\u0131 al\u0131nd\u0131<\/li> <li><strong>Ger\u00e7ek d\u00fcnya ba\u015far\u0131s\u0131<\/strong>: Son anketlerde %90 hasta tolerans oran\u0131<\/li> <li><strong>\u00dcr\u00fcn hatt\u0131 ilerlemesi<\/strong>: Subkutan form\u00fclasyon geli\u015ftirme a\u015famas\u0131nda<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5\u2019inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknolojiye ay\u0131rmay\u0131n<\/li> <li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> - Birka\u00e7 ay boyunca 100-200 $ aras\u0131 al\u0131mlar yap\u0131n<\/li> <li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong> - Maksimum %15-20 zarar tolerans\u0131<\/li> <li><strong>Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin<\/strong> - Bu, belirleyici an olabilir<\/li> <\/ol> <p>Esprili bir yorum: \"TGTX ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir - deneyler ba\u015far\u0131l\u0131 oldu\u011funda inan\u0131lmaz heyecan verici, ama laboratuvarda ara s\u0131ra patlamalara haz\u0131rl\u0131kl\u0131 olun!\"<\/p> <h2>\u2705 TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ hisseleri ve par\u00e7al\u0131 hisse sunan bir platform olmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"TGTX\" aramas\u0131 yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>\u0130nceleyin ve onaylay\u0131n<\/td><td>Komisyon \u00fccretlerini kontrol edin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonunuzu takip edin<\/td><td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc eri\u015filebilirlik sunar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong> - Ger\u00e7ek para ile strateji test etmek i\u00e7in ideal, ancak d\u00fc\u015f\u00fck riskli<\/li> <li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> - Tek belge y\u00fcklemesi ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flayabilirsiniz<\/li> <li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> - Kripto paralar ve e-c\u00fczdanlar dahil 100\u2019den fazla y\u00f6ntem<\/li> <li><strong>Par\u00e7al\u0131 hisse imkan\u0131<\/strong> - TGTX gibi pahal\u0131 hisselerin par\u00e7alar\u0131n\u0131 b\u00fct\u00e7enizi zorlamadan sat\u0131n al\u0131n<\/li> <\/ul> <p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, biyoteknoloji volatilitesini yeni ba\u015flayanlar i\u00e7in \u00e7ok daha az korkutucu hale getiriyor.<\/p> <h2>\ud83c\udf0d 2025\u2019te TG Therapeutics: MS Tedavisinde Yenilik\u00e7i<\/h2> <p>TG Therapeutics, BRIUMVI ile multipl skleroz i\u00e7in B h\u00fccre tedavisi alan\u0131nda hakimiyet kuruyor ve k\u00f6kl\u00fc rakiplerden \u00f6nemli pazar pay\u0131 kap\u0131yor. \u015eirketin <a href=\"https:\/\/www.tgtherapeutics.com\">yenilik\u00e7i yakla\u015f\u0131m\u0131<\/a> CD20 hedefli tedavilerde hasta bak\u0131m\u0131n\u0131 iyile\u015ftiren tolerans ve etkinlik profilleriyle devrim yaratt\u0131.<\/p> <p>Mevcut piyasa konumu: <strong>4,1 milyar $ piyasa de\u011feri<\/strong> ve 454 milyon $ gelir ile %86,96 br\u00fct marj - b\u00fcy\u00fcme a\u015famas\u0131ndaki bir biyoteknoloji i\u00e7in ola\u011fan\u00fcst\u00fc verimlilik.<\/p> <p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025\u2019te TG Therapeutics ara\u015ft\u0131rma ekibi, BRIUMVI hastalar\u0131n\u0131n %90\u2019\u0131n\u0131n \u00f6n ila\u00e7 olarak asetaminofen kulland\u0131\u011f\u0131n\u0131 ke\u015ffetti; bu beklenmedik \u015fekilde klinik deneme sonu\u00e7lar\u0131n\u0131n \u00f6tesinde tolerans oranlar\u0131n\u0131 art\u0131rd\u0131 - rutin a\u011fr\u0131 kesici kullan\u0131m\u0131 rekabet avantaj\u0131na d\u00f6n\u00fc\u015ft\u00fc!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 TG Therapeutics Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>20 A\u011fustos 2025 itibar\u0131yla TG Therapeutics, Inc. (TGTX) NASDAQ&#8217;ta <strong>28,08 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>3-5 Kas\u0131m 2025<\/strong> kesinlikle kritik &#8211; \u015firketin 3. \u00e7eyrek kazan\u00e7 raporlar\u0131n\u0131 a\u00e7\u0131klad\u0131\u011f\u0131 tarih. Tarihsel olarak, bu raporlar b\u00fcy\u00fck fiyat hareketlerine neden olur.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 TGTX Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>34,20 $<\/td>\n<td><strong>-%18<\/strong> (kazan\u00e7 hedefi ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>5 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>32,80 $<\/td>\n<td><strong>+%8,5<\/strong> (gelir beklentisi a\u015f\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>10 \u015eub 2025<\/td>\n<td>Y\u0131ll\u0131k Sonu\u00e7lar<\/td>\n<td>29,50 $<\/td>\n<td><strong>+%12<\/strong> (yol g\u00f6sterici art\u0131\u015f\u0131)<\/td>\n<\/tr>\n<tr>\n<td>4 Kas 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>27,80 $<\/td>\n<td><strong>+%15<\/strong> (BRIUMVI b\u00fcy\u00fcmesi)<\/td>\n<\/tr>\n<tr>\n<td>5 A\u011fu 2024<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>25,10 $<\/td>\n<td><strong>+%22<\/strong> (pazar geni\u015flemesi)<\/td>\n<\/tr>\n<tr>\n<td>6 May 2024<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>22,40 $<\/td>\n<td><strong>+%18<\/strong> (FDA g\u00fcncellemeleri)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: TGTX, kazan\u00e7 raporlar\u0131na kar\u015f\u0131 a\u015f\u0131r\u0131 duyarl\u0131l\u0131k g\u00f6steriyor ve ortalama \u00b1%15 dalgalanma ya\u015fan\u0131yor. Pozitif s\u00fcrprizler patlay\u0131c\u0131 kazan\u00e7lar yarat\u0131rken, hedef ka\u00e7\u0131rmalar keskin d\u00fc\u015f\u00fc\u015flere neden oluyor. Son 2. \u00e7eyrek sonras\u0131 %18\u2019lik d\u00fc\u015f\u00fc\u015f, bu biyoteknoloji hissesinin ne kadar volatil olabilece\u011fini g\u00f6steriyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>TG Therapeutics hisseleri ini\u015f \u00e7\u0131k\u0131\u015flarla dolu bir yolculuk ya\u015fad\u0131, toplamda <strong>%19,2<\/strong> d\u00fc\u015ft\u00fc ancak inan\u0131lmaz volatilite g\u00f6sterdi:<\/p>\n<p><strong>\u015eubat<\/strong>: 34,70 $ (y\u0131ll\u0131k rapor sonras\u0131 zirve)<br \/> <strong>Mart<\/strong>: 38,90 $ (BRIUMVI sat\u0131\u015f ivmesi)<br \/> <strong>Nisan<\/strong>: 36,20 $ (kar realizasyonu d\u00f6nemi)<br \/> <strong>May\u0131s<\/strong>: 35,60 $ (1. \u00e7eyrek kazan\u00e7 sindirimi)<br \/> <strong>Haziran<\/strong>: 32,80 $ (piyasa belirsizli\u011fi)<br \/> <strong>Temmuz<\/strong>: 29,40 $ (sekt\u00f6r genelinde biyoteknoloji sat\u0131\u015flar\u0131)<br \/> <strong>A\u011fustos<\/strong>: 28,08 $ (2. \u00e7eyrek kazan\u00e7 sonras\u0131 d\u00fc\u015f\u00fc\u015f)<\/p>\n<p>Volatilitenin sebebi nedir? Biyoteknoloji hisseleri klinik veriler ve \u00e7eyreklik sonu\u00e7lara ba\u011fl\u0131 olarak y\u00fckselir ya da d\u00fc\u015fer. TGTX\u2019in %91 gelir art\u0131\u015f\u0131, 2. \u00e7eyrekteki hisse ba\u015f\u0131na kazan\u00e7 hedefinin ka\u00e7\u0131r\u0131lmas\u0131n\u0131 telafi edemedi; bu sekt\u00f6rde m\u00fckemmellik beklendi\u011fini g\u00f6steriyor.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<h3>2025 (Y\u0131l Sonu): 32-38 $<\/h3>\n<p>Y\u00fckseltilmi\u015f BRIUMVI rehberli\u011fi 570-575 milyon $ ve olas\u0131 3. \u00e7eyrek toparlanmas\u0131na dayanarak \u2192 <strong>d\u00fc\u015f\u00fc\u015flerde AL<\/strong><\/p>\n<h3>2026: 45-52 $<\/h3>\n<p>Yeni b\u00f6lgelere pazar geni\u015flemesi ve olas\u0131 subkutan form\u00fclasyon onay\u0131 bekleniyor<\/p>\n<h3>2028: 60-75 $<\/h3>\n<p>\u00dcr\u00fcn hatt\u0131n\u0131n olgunla\u015fmas\u0131 ve BRIUMVI i\u00e7in multipl skleroz d\u0131\u015f\u0131 yeni endikasyonlar<\/p>\n<h3>2030: 85-110 $<\/h3>\n<p>B h\u00fccre tedavilerinde pazar liderli\u011fi ve b\u00fcy\u00fck ila\u00e7 \u015firketleri i\u00e7in potansiyel sat\u0131n alma hedefi<\/p>\n<p><strong>Sonu\u00e7<\/strong>: K\u0131sa vadeli volatiliteye ra\u011fmen g\u00fc\u00e7l\u00fc uzun vadeli tutma potansiyeli. Zay\u0131fl\u0131k d\u00f6nemlerinde biriktirin.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Pozitif Sinyaller<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>A\u015f\u0131r\u0131 volatilite<\/strong>: %2,84 g\u00fcnl\u00fck dalgalanmalar normaldir (<a href=\"https:\/\/stockinvest.us\/stock\/TGTX\">StockInvest Verileri<\/a>)<\/li>\n<li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA incelemesi ilerlemeyi an\u0131nda durdurabilir<\/li>\n<li><strong>Nakit yak\u0131m\u0131<\/strong>: Negatif 87 milyon $ serbest nakit ak\u0131\u015f\u0131 s\u00fcrekli finansman gerektirir<\/li>\n<li><strong>Klinik deneme ba\u015far\u0131s\u0131zl\u0131klar\u0131<\/strong>: Herhangi bir \u00fcr\u00fcn hatt\u0131 gerilemesi hissenin %30-50 d\u00fc\u015fmesine yol a\u00e7abilir<\/li>\n<li><strong>Rekabet<\/strong>: Daha derin kaynaklara sahip b\u00fcy\u00fck ila\u00e7 \u015firketleri<\/li>\n<\/ul>\n<h3>2025 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>Patlay\u0131c\u0131 b\u00fcy\u00fcme<\/strong>: Y\u0131ll\u0131k %91 BRIUMVI gelir art\u0131\u015f\u0131 (<a href=\"https:\/\/www.stocktitan.net\/news\/TGTX\/tg-therapeutics-reports-second-quarter-2025-financial-results-and-gk27yackstrn.html\">2. \u00c7eyrek Raporu<\/a>)<\/li>\n<li><strong>Y\u00fckseltilmi\u015f rehberlik<\/strong>: 570-575 milyon $ hedefi y\u00f6netim g\u00fcvenini g\u00f6steriyor<\/li>\n<li><strong>Pazar geni\u015flemesi<\/strong>: AB, \u0130ngiltere, \u0130svi\u00e7re onaylar\u0131 al\u0131nd\u0131<\/li>\n<li><strong>Ger\u00e7ek d\u00fcnya ba\u015far\u0131s\u0131<\/strong>: Son anketlerde %90 hasta tolerans oran\u0131<\/li>\n<li><strong>\u00dcr\u00fcn hatt\u0131 ilerlemesi<\/strong>: Subkutan form\u00fclasyon geli\u015ftirme a\u015famas\u0131nda<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %3-5\u2019inden fazlas\u0131n\u0131 y\u00fcksek volatiliteye sahip biyoteknolojiye ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar maliyeti ortalamas\u0131 yap\u0131n<\/strong> &#8211; Birka\u00e7 ay boyunca 100-200 $ aras\u0131 al\u0131mlar yap\u0131n<\/li>\n<li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong> &#8211; Maksimum %15-20 zarar tolerans\u0131<\/li>\n<li><strong>Kas\u0131m kazan\u00e7lar\u0131n\u0131 takip edin<\/strong> &#8211; Bu, belirleyici an olabilir<\/li>\n<\/ol>\n<p>Esprili bir yorum: &#8220;TGTX ticareti, parlak bir bilim insan\u0131yla \u00e7\u0131kmak gibidir &#8211; deneyler ba\u015far\u0131l\u0131 oldu\u011funda inan\u0131lmaz heyecan verici, ama laboratuvarda ara s\u0131ra patlamalara haz\u0131rl\u0131kl\u0131 olun!&#8221;<\/p>\n<h2>\u2705 TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ hisseleri ve par\u00e7al\u0131 hisse sunan bir platform olmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Risk almaya haz\u0131r oldu\u011funuz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;TGTX&#8221; aramas\u0131 yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f t\u00fcr\u00fcn\u00fc se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonunuzu takip edin<\/td>\n<td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Yat\u0131r\u0131m yolculu\u011funa yeni ba\u015flayanlar i\u00e7in Pocket Option ola\u011fan\u00fcst\u00fc eri\u015filebilirlik sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong> &#8211; Ger\u00e7ek para ile strateji test etmek i\u00e7in ideal, ancak d\u00fc\u015f\u00fck riskli<\/li>\n<li><strong>\u015eim\u015fek h\u0131z\u0131nda do\u011frulama<\/strong> &#8211; Tek belge y\u00fcklemesi ile dakikalar i\u00e7inde i\u015flem yapmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>\u00c7e\u015fitli para \u00e7ekme se\u00e7enekleri<\/strong> &#8211; Kripto paralar ve e-c\u00fczdanlar dahil 100\u2019den fazla y\u00f6ntem<\/li>\n<li><strong>Par\u00e7al\u0131 hisse imkan\u0131<\/strong> &#8211; TGTX gibi pahal\u0131 hisselerin par\u00e7alar\u0131n\u0131 b\u00fct\u00e7enizi zorlamadan sat\u0131n al\u0131n<\/li>\n<\/ul>\n<p>Platformun kullan\u0131c\u0131 dostu aray\u00fcz\u00fc, biyoteknoloji volatilitesini yeni ba\u015flayanlar i\u00e7in \u00e7ok daha az korkutucu hale getiriyor.<\/p>\n<h2>\ud83c\udf0d 2025\u2019te TG Therapeutics: MS Tedavisinde Yenilik\u00e7i<\/h2>\n<p>TG Therapeutics, BRIUMVI ile multipl skleroz i\u00e7in B h\u00fccre tedavisi alan\u0131nda hakimiyet kuruyor ve k\u00f6kl\u00fc rakiplerden \u00f6nemli pazar pay\u0131 kap\u0131yor. \u015eirketin <a href=\"https:\/\/www.tgtherapeutics.com\">yenilik\u00e7i yakla\u015f\u0131m\u0131<\/a> CD20 hedefli tedavilerde hasta bak\u0131m\u0131n\u0131 iyile\u015ftiren tolerans ve etkinlik profilleriyle devrim yaratt\u0131.<\/p>\n<p>Mevcut piyasa konumu: <strong>4,1 milyar $ piyasa de\u011feri<\/strong> ve 454 milyon $ gelir ile %86,96 br\u00fct marj &#8211; b\u00fcy\u00fcme a\u015famas\u0131ndaki bir biyoteknoloji i\u00e7in ola\u011fan\u00fcst\u00fc verimlilik.<\/p>\n<p><strong>\u0130lgin\u00e7 Ger\u00e7ek<\/strong>: 2025\u2019te TG Therapeutics ara\u015ft\u0131rma ekibi, BRIUMVI hastalar\u0131n\u0131n %90\u2019\u0131n\u0131n \u00f6n ila\u00e7 olarak asetaminofen kulland\u0131\u011f\u0131n\u0131 ke\u015ffetti; bu beklenmedik \u015fekilde klinik deneme sonu\u00e7lar\u0131n\u0131n \u00f6tesinde tolerans oranlar\u0131n\u0131 art\u0131rd\u0131 &#8211; rutin a\u011fr\u0131 kesici kullan\u0131m\u0131 rekabet avantaj\u0131na d\u00f6n\u00fc\u015ft\u00fc!<\/p>\n"},"faq":[{"question":"TG Therapeutics hisseleri nereden al\u0131nabilir?","answer":"TG Therapeutics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden TGTX sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"BRIUMVI ilac\u0131n\u0131n TG Therapeutics i\u00e7in \u00f6nemi nedir?","answer":"BRIUMVI, TG Therapeutics'in multipl skleroz tedavisinde \u00f6ne \u00e7\u0131kan ana ilac\u0131d\u0131r ve \u015firketin gelirlerinde patlay\u0131c\u0131 b\u00fcy\u00fcme sa\u011flamaktad\u0131r."},{"question":"TG Therapeutics hisselerinde volatilite neden y\u00fcksektir?","answer":"Biyoteknoloji hisseleri klinik veriler ve \u00e7eyreklik kazan\u00e7 raporlar\u0131na \u00e7ok duyarl\u0131d\u0131r. TGTX hissesi de bu raporlara ba\u011fl\u0131 olarak b\u00fcy\u00fck fiyat dalgalanmalar\u0131 ya\u015famaktad\u0131r."},{"question":"Yeni ba\u015flayan biri TG Therapeutics hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131p dolar maliyeti ortalamas\u0131 yaparak, s\u0131k\u0131 stop-loss seviyeleri belirleyerek ve \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip ederek yat\u0131r\u0131m yapmak \u00f6nerilir."},{"question":"Pocket Option TG Therapeutics hisseleri i\u00e7in neden uygun bir platformdur?","answer":"Pocket Option d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7e\u015fitli para \u00e7ekme se\u00e7enekleri ve par\u00e7al\u0131 hisse al\u0131m imkan\u0131 sunarak yeni yat\u0131r\u0131mc\u0131lar i\u00e7in eri\u015filebilir ve kullan\u0131c\u0131 dostu bir platformdur."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"TG Therapeutics hisseleri nereden al\u0131nabilir?","answer":"TG Therapeutics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden TGTX sembol\u00fc ile al\u0131m yapabilirsiniz."},{"question":"BRIUMVI ilac\u0131n\u0131n TG Therapeutics i\u00e7in \u00f6nemi nedir?","answer":"BRIUMVI, TG Therapeutics'in multipl skleroz tedavisinde \u00f6ne \u00e7\u0131kan ana ilac\u0131d\u0131r ve \u015firketin gelirlerinde patlay\u0131c\u0131 b\u00fcy\u00fcme sa\u011flamaktad\u0131r."},{"question":"TG Therapeutics hisselerinde volatilite neden y\u00fcksektir?","answer":"Biyoteknoloji hisseleri klinik veriler ve \u00e7eyreklik kazan\u00e7 raporlar\u0131na \u00e7ok duyarl\u0131d\u0131r. TGTX hissesi de bu raporlara ba\u011fl\u0131 olarak b\u00fcy\u00fck fiyat dalgalanmalar\u0131 ya\u015famaktad\u0131r."},{"question":"Yeni ba\u015flayan biri TG Therapeutics hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"K\u00fc\u00e7\u00fck miktarlarla ba\u015flay\u0131p dolar maliyeti ortalamas\u0131 yaparak, s\u0131k\u0131 stop-loss seviyeleri belirleyerek ve \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip ederek yat\u0131r\u0131m yapmak \u00f6nerilir."},{"question":"Pocket Option TG Therapeutics hisseleri i\u00e7in neden uygun bir platformdur?","answer":"Pocket Option d\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7e\u015fitli para \u00e7ekme se\u00e7enekleri ve par\u00e7al\u0131 hisse al\u0131m imkan\u0131 sunarak yeni yat\u0131r\u0131mc\u0131lar i\u00e7in eri\u015filebilir ve kullan\u0131c\u0131 dostu bir platformdur."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T12:18:39+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-20T12:18:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/\",\"name\":\"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-20T12:18:39+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T12:18:39+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-20T12:18:39+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/","name":"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r - TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-20T12:18:39+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-tg-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"TG Therapeutics, Inc. (TGTX) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; TG Therapeutics, Inc. (TGTX) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":340720,"slug":"how-to-buy-tg-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu TG Therapeutics, Inc. (TGTX) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu TG Therapeutics, Inc. (TGTX)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-tg-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":340715,"slug":"how-to-buy-tg-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da TG Therapeutics, Inc. (TGTX) - Investimento em a\u00e7\u00f5es da TG Therapeutics, Inc. (TGTX)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-tg-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=340717"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/340717\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=340717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=340717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=340717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}